Mean platelet volume/platelet count ratio as a predictor of long-term mortality after non-ST-elevation myocardial infarction

Platelets

Volumn 22, Issue 8, 2011, Pages 557-566

  Azab, Basem ^a   Torbey, Estelle ^a   Singh, Jasvinder ^a   Akerman, Meredith ^b   Khoueiry, Georges ^a   McGinn Jr , Joseph T ^a   Widmann, Warren D ^a   Lafferty, James ^a  

^a STATEN ISLAND UNIVERSITY HOSPITAL   (United States)

^b DONALD AND BARBARA ZUCKER SCHOOL OF MEDICINE AT HOFSTRA NORTHWELL   (United States)

Author keywords

MPV; NSTEMI; Platelet

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; CREATININE; GLUCOSE; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; TROPONIN;

ADULT; AGED; ANGIOPLASTY; ANTICOAGULANT THERAPY; COMBINATION CHEMOTHERAPY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; FEMALE; GLUCOSE BLOOD LEVEL; HEART ATRIUM FIBRILLATION; HEART FAILURE; HUMAN; HUMAN TISSUE; LIPOPROTEIN BLOOD LEVEL; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MORTALITY; NEUTROPHIL COUNT; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; OUTCOME ASSESSMENT; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RETROSPECTIVE STUDY; REVIEW; RISK ASSESSMENT; SCORING SYSTEM; SEX DIFFERENCE; THROMBOCYTE COUNT; THROMBOCYTE VOLUME;

HUMANS; MYOCARDIAL INFARCTION; PLATELET AGGREGATION INHIBITORS; PLATELET COUNT; PROGNOSIS;

MOROCCAN PEPPER VIRUS;

EID: 80455168375     PISSN: 09537104     EISSN: 13691635     Source Type: Journal    
DOI: 10.3109/09537104.2011.584086     Document Type: Review

References (42)

1. Gasparyan AY, Ayvazyan L, Mikhailidis DP, Kitas GD. Mean platelet volume: A link between thrombosis and inflammation? Curr Pharm Des 2011;17(1):47-58.
2. Gasparyan AY, Stavropoulos-Kalinoglou A, Toms TE, Douglas KM, Kitas GD. Association of mean platelet volume with hypertension in rheumatoid arthritis. Inflamm Allergy Drug Targets 2010;9(1):45-50.
3. Kiliçli-Camur N, Demirtunc R, Konuralp C, Eskiser A, Basaran Y. Could mean platelet volume be a predictive marker for acute myocardial infarction? Med Sci Monit 2005;11:CR387-CR392. (Pubitemid 41224401)
4. Yilmaz MB, Cihan G, Guray Y, Guray U, Kisacik HL, Sasmaz H, Korkmaz S. Role of mean platelet volume in triagging acute coronary syndromes. J Thromb Thrombolysis 2008;26:49-54.
5. Norgaz T, Hobikoglu G, Aksu H, Bolca O, Uyarel H, Eren M, Narin A. The relationship between preprocedural platelet size and subsequent in-stent restenosis. Acta Cardiol 2004;59:391-395. (Pubitemid 39056123)
6. Yang A, Pizzulli L, Luderitz B. Mean platelet volume as marker of restenosis after percutaneous transluminal coronary angioplasty in patients with stable and unstable angina pectoris. Thromb Res 2006;117:371-377. (Pubitemid 43197487)
7. Roldan V, Cuenca AL, Perez-Berbel P, Mainar L, Tello-Montoliu A, Jover E, Hernandez-Romero D, Valdes M, Vicente V, Marin F. Mean platelet volume and prognosis in non ST elevation acute coronary syndrome. Eur Heart J 2010;31(Suppl 1):54-54.
8. Huczek Z, Kochman J, Filipiak KJ, Horszczaruk GJ, Grabowski M, Piatkowski R, Wilczynska J, Zielinski A, Meier B, Opolski G. Mean platelet volume on admission predicts impaired reperfusion and long-term mortality in acute myocardial infarction treated with primary percutaneous coronary intervention. J Am Coll Cardiol 2005;46:284-290. (Pubitemid 40966857)
9. Pabon Osuna P, Nieto Ballesteros F, Morinigo Munoz JL, Sanchez Fernandez PL, Arribas Jimenez A, Diego Dominguez M, Martin Luengo C. The effect of the mean platelet volume on the short-term prognosis of acute myocardial infarct. Rev Esp Cardiol 1998;51:816-822.
10. Martin JF, Bath PM, Burr ML. Influence of platelet size on outcome after myocardial infarction. Lancet 1991;338: 1409-1411.
11. Goncalves SC, Labinaz M, Le May M, Glover C, Froeschl M, Marquis JF, O'Brien E, Shukla D, Ruchin P, Sookur D, et al. Usefulness of mean platelet volume as a biomarker for long-term outcomes after percutaneous coronary intervention. Am J Cardiol 2011;107(2):204-209.
12. Park CS, Ihm SH, Yoo KD, Kim DB, Lee JM, Kim HY, Chung WS, Seung KB, Kim JH. Relation between C-reactive protein, homocysteine levels, fibrinogen, and lipoprotein levels and leukocyte and platelet counts, and 10-year risk for cardiovascular disease among healthy adults in the USA. Am J Cardiol 2010;105(9):1284-1288.
13. Johansen O, Brekke M, Seljeflot I, Semb AG, Arnesen H. Blood platelet count and reactivity are associated with restenosis 6 months after coronary angioplasty. Scand Cardiovasc J 2004;38:211-215. (Pubitemid 39172838)
14. Turakhia MP, Murphy SA, Pinto TL, Antman EM, Giugliano RP, Cannon CP, Braunwald E, Gibson CM. Thrombolysis in Myocardial Infarction Study Group Association of platelet count with residual thrombus in the myocardial infarct-related coronary artery among patients treated with fibrinolytic therapy for ST-segment elevation acute myocardial infarction. Am J Cardiol 2004;94: 1406-1410. (Pubitemid 39556211)
15. Mueller C, Neumann FJ, Hochholzer W, Trenk D, Zeller T, Perruchoud AP, Buettner HJ. The impact of platelet count on mortality in unstable angina/non-ST-segment elevation myocardial infarction. Am Heart J 2006;151(6):1214.e1-1214.e7.
16. Nikolsky E, Grines CL, Cox DA, Garcia E, Tcheng JE, Sadeghi M, Mehran R, Lansky AJ, Na Y, Stone GW. Impact of baseline platelet count in patients undergoing primary percutaneous coronary intervention in acute myocardial infarction (from the CADILLAC trial). Am J Cardiol 2007;99:1055-1061. (Pubitemid 46560468)
17. Iijima R, Ndrepepa G, Mehilli J, Bruskina O, Schulz S, Schomig A, Kastrati A. Relationship between platelet count and 30-day clinical outcomes after percutaneous coronary interventions: Pooled analysis of four ISAR trials. Thromb Haemost 2007;98:852-857. (Pubitemid 47555079)
18. Ranjith MP, Divya R, Mehta VK, Krishnan MG, KamalRaj R, Kavishwar A. Significance of platelet volume indices and platelet count in ischaemic heart disease. J Clin Pathol 2009;62(9):830-833.
19. Bessman JD, Williams LJ, Gilmer Jr PR. Mean platelet volume. The inverse relation of platelet size and count in normal subjects, and an artifact of other particles. Am J Clin Pathol 1981;76(3):289-293. (Pubitemid 11057440)
20. Lamparelli RD, Baynes RD, Atkinson P, Bezwoda WR, Mendelow BV. Platelet parameters. Part I. Platelet counts and mean platelet volume in normal and pregnant subjects. S Afr Med J 1988;73(1):36-39. (Pubitemid 18066207)
21. Lozano M, Narváez J, Faúndez A, Mazzara R, Cid J, Jou JM, Maŕn JL, Ordinas A. Platelet count and mean platelet volume in the Spanish population. Med Clin (Barc) 1998;110(20):774-777. (Pubitemid 128530193)
22. Granger CB, Goldberg RJ, Dabbous O, Pieper KS, Eagle KA, Cannon CP, Van De Werf F, Avezum A, Goodman SG, Flather MD, et al. Predictors of hospital mortality in the global registry of acute coronary events. Arch Intern Med 2003;163:2345-2353. (Pubitemid 37310196)
23. Tang EW, Wong CK, Herbison P. Global Registry of Acute Coronary Events (GRACE) hospital discharge risk score accurately predicts long-term mortality post acute coronary syndrome. Am Heart J 2007;153:29-35. (Pubitemid 44880880)
24. Bigalke B, Stellos K, Stakos D, Joos T, Pö tz O, Geisler T, Bischofs C, Kremmer E, Krämer BF, Seizer P, et al. Influence of platelet count on the expression of platelet collagen receptor glycoprotein VI (GPVI) in patients with acute coronary syndrome. Thromb Haemost 2009;101(5):911-915.
25. Jaremo P, Hansson G, Nilsson O. Elevated inflammatory parameters are associated with lower platelet density in acute myocardial infarctions with ST-elevation. Thromb Res 2000;100:471-478. (Pubitemid 32056299)
26. Tsiara S, Elisaf M, Jagroop IA, Mikhailidis DP. Platelets as predictors of vascular risk: Is there a practical index of platelet activity? Clin Appl Thromb Hemost 2003;9:177-190. (Pubitemid 37070125)
27. Griesshammer M, Bangerter M, Sauer T, Wennauer R, Bergmann L, Heimpel H. Aetiology and clinical significance of thrombocytosis: Analysis of 732 patients with an elevated platelet count. J Intern Med 1999;245(3):295-300. (Pubitemid 29132973)
28. Aydogan T, Kanbay M, Alici O, Kosar A. Incidence and etiology of thrombocytosis in an adult Turkish population. Platelets 2006;17(5):328-331. (Pubitemid 44277699)
29. Sehayek E, Ben-Yosef N, Modan M, Chetrit A, Meytes D. Platelet parameters and aggregation in essential and reactive thrombocytosis. Am J Clin Pathol 1988;90(4):431-436.
30. Van der Lelie J, Von dem Borne AK. Platelet volume analysis for differential diagnosis of thrombocytosis. J Clin Pathol 1986;39(2):129-133. (Pubitemid 16144966)
31. Haznedarog̈ lu IC, Ertenli I, Ozcebe OI, Kiraz S, Ozdemir O, Sayinalp NM, Dü ndar SV, Calgü neri M, Kirazli S. Megakaryocyte-related interleukins in reactive thrombocytosis versus autonomous thrombocythemia. Acta Haematol 1996;95(2):107-111. (Pubitemid 26110053)
32. Ceresa IF, Noris P, Ambaglio C, Pecci A, Balduini CL. Thrombopoietin is not uniquely responsible for thrombocytosis in inflammatory disorders. Platelets 2007;18(8): 579-582. (Pubitemid 350179039)
33. Dan K, Gomi S, Inokuchi K, Ogata K, Yamada T, Ohki I, Hasegawa S, Nomura T. Effects of interleukin-1 and tumor necrosis factor on megakaryocytopoiesis: Mechanism of reactive thrombocytosis. Acta Haematol 1995;93(2-4):67-72.
34. Lindmark E, Diderholm E, Wallentin L, Siegbahn A. Relationship between interleukin 6 and mortality in patients with unstable coronary artery disease: Effects of an early invasive or noninvasive strategy. JAMA 2001;286(17): 2107-2113. (Pubitemid 34041595)
35. Ridker PM, Rifai N, Pfeffer M, Sacks F, Lepage S, Braunwald E. Elevation of tumor necrosis factor-alpha and increased risk of recurrent coronary events after myocardial infarction. Circulation 2000;101(18):2149-2153. (Pubitemid 30253042)
36. Li N, Hu H, Lindqvist M, Wikström-Jonsson E, Goodall AH, Hjemdahl P. Platelet-leukocyte cross talk in whole blood. Arterioscler Thromb Vasc Biol 2000;20(12):2702-2708.
37. Li S, Salhany KE. Spurious elevation of automated platelet counts in secondary acute monocytic leukemia associated with tumor lysis syndrome. Arch Pathol Lab Med 1999;123(11): 1111-1114. (Pubitemid 29526680)
38. Di Giovanni S, De Matteis MA, Ciocca D, Cirella MP, Nanni Costa MP. Pseudothrombocytosis and pseudoleukocytosis in a case of essential mixed cryoglobulinemia (type II). Clin Exp Rheumatol 1986;4(2):143-145. (Pubitemid 16056602)
39. Guthikonda S, Alviar CL, Vaduganathan M, Arikan M, Tellez A, DeLao T, Granada JF, Dong JF, Kleiman NS, Lev EI. Role of reticulated platelets and platelet size heterogeneity on platelet activity after dual antiplatelet therapy with aspirin and clopidogrel in patients with stable coronary artery disease. J Am Coll Cardiol 2008;52(9):743-749.
40. Gasparyan AY. Aspirin and clopidogrel resistance: Methodological challenges and opportunities. Vasc Health Risk Manag 2010;6:109-112.
41. Kayacioglu I, Gunay R, Saskin H, Idiz M, Sensoz Y, Ates M, Tangurek B, Alper AT, Demirtas MM, Yekeler I. The role of clopidogrel and acetylsalicylic acid in the prevention of earlyphase graft occlusion due to reactive thrombocytosis after coronary artery bypass operation. Heart Surg Forum 2008;11(3):E152-E157.
42. Cannon CP, Braunwald E. Unstable angina and Non-ST elevation myocardial infarction. In: Libby P, Bonow RO, Mann DL, and Zipes DP, editors. Braunwald's heart disease. Philadelphia: Saunders Elsevier; 2008. pp 1319-1351.